Targeting Oncogenic Super Enhancers in MYC-Dependent AML Using a Small Molecule Activator of NR4A Nuclear Receptors. [electronic resource]
Producer: 20201113Description: 2851 p. digitalISSN:- 2045-2322
- Animals
- Cell Cycle Proteins -- genetics
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cellular Reprogramming -- genetics
- Dihydroergotamine -- pharmacology
- E1A-Associated p300 Protein -- genetics
- Enhancer Elements, Genetic -- genetics
- Epigenesis, Genetic -- genetics
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Leukemia, Myeloid, Acute -- drug therapy
- Mice
- Nuclear Receptor Subfamily 4, Group A, Member 1 -- agonists
- Oncogenes -- genetics
- Proto-Oncogene Proteins c-myc -- genetics
- Signal Transduction -- drug effects
- Transcription Factors -- genetics
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.